TRAVERE THERAPEUTICS INC (TVTX) Earnings History & Surprises

NASDAQ:TVTX • US89422G1076

28.63 USD
-0.35 (-1.21%)
At close: Mar 10, 2026
28.63 USD
0 (0%)
After Hours: 3/10/2026, 8:00:01 PM

Past quarterly earnings results for TRAVERE THERAPEUTICS INC (TVTX), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release DateApr 29, 2026
PeriodQ1 / 2026
EPS Estimate-$0.20
Revenue Estimate139.52M

Last Reported

Most Recent
Release DateJan 12, 2026
PeriodQ4 / 2025
EPS Reported$0.03
EPS Surprise 124.93%
Revenue Surprise -10.61%

Beat Rate

Last 8 Quarters
56%
EPS and Revenuebeats vs estimates

Quarterly Earnings Results

EPS & Revenue History (USD)

Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q4 2025 0.03 -0.12 124.93% 104.11% 129.689M 145.08M -10.61% 73.41%
Q3 2025 0.28 -0.21 232.09% 140.00% 164.859M 108.66M 51.72% 162.11%
Q2 2025 -0.14 -0.30 53.91% 84.62% 114.449M 102.66M 11.48% 111.49%
Q1 2025 -0.47 -0.55 14.67% 73.30% 81.732M 77.043M 6.09% 97.54%
Q4 2024 -0.73 -0.57 -27.29% 29.13% 74.787M 74.802M -0.02% 65.98%
Q3 2024 -0.70 -0.69 -1.00% 40.17% 62.898M 61.685M 1.97% 69.56%
Q2 2024 -0.91 -0.88 -3.62% 19.47% 54.116M 51.172M 5.75% -9.35%
Q1 2024 -1.76 -1.01 -74.13% -38.58% 41.374M 43.704M -5.33% -27.41%
Q4 2023 -1.03 -1.30 20.64% - 45.059M 42.089M 7.06% -19.35%
Q3 2023 -1.17 -0.15 -703.66% -7.34% 37.095M 121.12M -69.37% 32.10%
Q2 2023 -1.13 -1.16 2.89% -7.62% 59.697M 54.786M 8.96% 1,576.88%
Q1 2023 -1.27 -1.19 -6.34% -5.83% 56.993M 51.621M 10.41% 17.54%
Q4 2022 -1.03 -1.10 6.02% -22.62% 55.87M 54.075M 3.32% -2.41%
Q3 2022 -1.09 -0.88 -23.68% -84.75% 28.08M 55.854M -49.73% -58.84%
Q2 2022 -1.05 -0.89 -17.48% -64.06% 3.56M 50.619M -92.97% -93.48%
Q1 2022 -1.20 -0.87 -38.18% -25.00% 48.49M 52.957M -8.44% 2.28%
Q4 2021 -0.84 -0.70 -20.52% -75.00% 57.25M 58.05M -1.38% 12.30%
Q3 2021 -0.59 -0.55 -7.52% -34.09% 68.22M 62.152M 9.76% 33.40%
Q2 2021 -0.64 -0.70 8.18% -10.34% 54.62M 51.337M 6.39% 12.78%
Q1 2021 -0.96 -0.40 -140.45% -4,900.00% 47.41M 51.089M -7.20% -0.75%
Q4 2020 -0.48 -0.48 0.40% - 50.98M 52.694M -3.25% -
Q3 2020 -0.44 -0.53 16.35% - 51.14M 48.81M 4.77% -
Q2 2020 -0.58 -0.57 -2.00% - 48.43M 48.015M 0.86% -
Q1 2020 0.02 -0.68 102.94% - 47.77M 44.296M 7.84% -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

TVTX EPS Q2Q GrowthTVTX EPS Q2Q GrowthEPS Q2Q Growth Q1/21 Q3/21 Q1/22 Q3/22 Q1/23 Q3/23 Q1/24 Q3/24 Q1/25 Q3/25 Q1/26 Q3/26 0 -2K -4K

Revenue Historical Q2Q growth and Acceleration

TVTX Revenue Q2Q GrowthTVTX Revenue Q2Q GrowthRevenue Q2Q Growth Q1/21 Q3/21 Q1/22 Q3/22 Q1/23 Q3/23 Q1/24 Q3/24 Q1/25 Q3/25 Q1/26 Q3/26 0 500 1K 1.5K

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
4
Average EPS beat (4)
106.40%
Max EPS beat (4)
232.09%
Min EPS beat (4)
14.67%

Revenue beat statistics

Revenue beat (4)
3
Average Revenue beat (4)
14.67%
Max Revenue beat (4)
51.72%
Min Revenue beat (4)
-10.61%

Analysis

In the last 4 quarters, TVTX has consistently beaten EPS estimates in all releases
TVTX has beaten revenue estimates in 3 out of the last 4 releases
In the last 4 quarters, TVTX has beaten the EPS estimates by 106.4% on average.
In the last 4 quarters, TVTX has beaten the revenue estimates by 14.7% on average.
→ Find peers who consistently beat earnings by at least 10% in the last 4 quarters

TRAVERE THERAPEUTICS INC / TVTX Earnings FAQ

When did TRAVERE THERAPEUTICS INC (TVTX) report earnings last quarter?

TRAVERE THERAPEUTICS INC (TVTX) last reported earnings on 1/12/2026.


Did TVTX stock beat earnings estimates in the most recent quarter?

TRAVERE THERAPEUTICS INC (TVTX) beat EPS estimates and missed revenue estimates in the most recent quarter.


How often does TRAVERE THERAPEUTICS INC (TVTX) beat earnings estimates?

In the last 4 quarters, TRAVERE THERAPEUTICS INC (TVTX) has beaten EPS estimates in 4 out of 4 releases.